ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FD02 | BioTech | Pertuzumab - 420mg/14ml | 7629/388 | 187053/13 | PERJETA 420MG | 420mg/14ml | 1 | Injectable concentrate for solution | Infusion | Omnipharma | Roche Diagnostics GmbH | Germany | L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 05/02/20 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FD02 | BioTech | Pertuzumab - 420mg/14ml | 7629 | 187053/13 | PERJETA 420MG | 420mg/14ml | 1 | Injectable concentrate for solution | Infusion | Omnipharma | Roche Diagnostics GmbH | Germany | 220,054,714 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 12/12/20 | 0 |